ASHLEY DOYLE: Open Payments
NPI 1790226652 · ODESSA, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,734 in 165 payments from 22 companies in 2025. Trend: 2023 $1,163 · 2024 $2,067 · 2025 $2,734
Food & beverage: $2,734
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $576 |
| Alkermes, Inc. | 10 | $314 |
| Bausch Health US, LLC | 28 | $274 |
| Tris Pharma Inc | 18 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $197 |
| Novo Nordisk Inc | 12 | $191 |
| Collegium Pharmaceutical, Inc. | 14 | $187 |
| Axsome Therapeutics, Inc. | 9 | $162 |
| Lundbeck LLC | 5 | $101 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
Products named: QULIPTA, APLENZIN, Dyanavel XR, TRINTELLIX, Jornay PM, Auvelity, REXULTI, VIVITROL.
Industry payments across DE — which companies pay providers there.
